Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 15 Recurrence 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Squamous Cell Carcinoma of Head and Neck 1 SCLC, Extensive Stage 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Medulloblastoma 1 Lung 1 Leukemia 1 Head and Neck Neoplasms 1 Extrapulmonary Neuroendocrine Cancer 1 Extensive Stage Lung Small Cell Cancer 1 Extensive Small Cell Lung Cancer 1 Ependymoma 1 ES-SCLC 1 Carcinoma, Squamous Cell 1 Carcinoma, Small Cell 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Merkel Cell 1 Carcinoma 1

Interventions

pembrolizumab 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 Specimen Handling 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Hematologic Tests 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Merkel Cell × Etoposide × Clear all

NCT06086288 2023-10-17

PANDORA

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡